As Big Pharma Continues to Hike Prices, Health Karma, Subsidiary of MediXall Group, Reduces Cost of Prescription Medications
ACCESSWIRE
05 May 2021, 22:43 GMT+10
PRESIDENT BIDEN'S AMERICAN FAMILIES PLAN UNVEILED LAST WEDNESDAY DOES NOT INCLUDE PROPOSAL TO CUT PRESRIPTION DRUG PRICES
FORT LAUDERDALE, FL / ACCESSWIRE / May 5, 2021 / MediXall Group, Inc. (OTCQB:MDXL) reported today that its subsidiary, Health Karma, is reducing the cost of prescription medications by delivering RX discounts to consumers through the Health Karma online platform. This comes at a critical time as Big Pharma continues to increase medication prices even as individuals are struggling through a pandemic and economic crisis.
According to a report by Patients for Affordable Drugs, 245 prescription drugs increased in price between January and June of 2020 in the thick of the pandemic with more than 75% of those drugs being used as a treatment for COVID-19. Healthcare research reports by 3 Axis Advisors and announcements from drug makers including Pfizer, Inc, Sanofi SA and GlaxoSmithKline Plc, shows plans for potential drug price hikes by as much as 10 percent in 2021. Estimates of over 700 drugs from multiple manufacturers showed varying price increases in January forcing consumes to choose between paying for their medication and other basic needs.